The surge in the anti-biofilm wound dressing market is largely attributed to the rising prevalence of acute and chronic wounds. As these conditions become more common, the need for innovative and ...
Merakris Therapeutics is pleased to announce that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial (NCT04647240) of its investigational wound care drug, Dermacyte ® ...